Corifollitropin alfa in a long GnRH agonist protocol: Proof of concept trial

Fertility and Sterility

Volumn 94, Issue 5, 2010, Pages 1922-1924

  Fatemi, Human M ^a   Oberyé, Janine ^b   Popovic Todorovic, Biljana ^a   Witjes, Han ^b   Mannaerts, Bernadette ^b   Devroey, Paul ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CORIFOLLITROPIN ALFA; GONADORELIN AGONIST; RECOMBINANT FOLLITROPIN; TRIPTORELIN; UNCLASSIFIED DRUG; FOLLICLE STIMULATING HORMONE, HUMAN, WITH HCG C-TERMINAL PEPTIDE; FOLLITROPIN; GONADORELIN; INHIBIN; INHIBIN B; RECOMBINANT PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE MATURATION; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT OUTCOME; ADOLESCENT; AGONISTS; CELL COUNT; COHORT ANALYSIS; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; OOCYTE; OOCYTE RETRIEVAL; OVARY FOLLICLE; OVULATION INDUCTION; PILOT STUDY; PREGNANCY; PREGNANCY RATE; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; CELL COUNT; CHORIONIC GONADOTROPIN; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, HUMAN; GONADOTROPIN-RELEASING HORMONE; HUMANS; INHIBINS; OOCYTE RETRIEVAL; OOCYTES; OVARIAN FOLLICLE; OVULATION INDUCTION; PILOT PROJECTS; PREGNANCY; PREGNANCY RATE; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 77957191145     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.12.070     Document Type: Article

References (21)

1. B.C.J.M. Fauser, B.M.J.L. Mannaerts, P. Devroey, A. Leader, I. Boime, and D.T. Baird Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency Hum Reprod Update 15 2009 309 321
2. P.M. Bouloux, D.J. Handelsman, F. Jockenhövel, E. Nieschlag, J. Rabinovici, and W.L. Frasa FSH-CTP study group. First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males Hum Reprod 16 2001 1592 1597
3. I.J. Duijkers, C. Klipping, P.J. Boerrigter, C.S. Machielsen, J.J. De Bie, and G. Voortman Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females Hum Reprod 17 2002 1987 1993
4. P. Devroey, B.C. Fauser, P. Platteau, N.G. Beckers, M. Dhont, and B.M. Mannaerts Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization J Clin Endocrinol Metab 89 2004 2062 2070
5. Corifollitropin Alfa Dose-Finding Study Group A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation Hum Reprod 23 2008 2484 2492
6. P. Devroey, R. Boostanfar, N.P. Koper, B.M.J.L. Mannaerts, P.C. IJzerman-Boon, and B.C. Fauser ENGAGE Investigators. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol Hum Reprod 24 2009 3063 3072
7. The corifollitropin alfa ENSURE study group. Cori-follitropin alfa for controlled ovarian stimulation in IVF treatment: results from a randomized trial in lower body weight women. Reprod Biomed Online 2010;21:66-76.
8. W. Ledger, A. Zandvliet, and B Mannaerts on behalf of the ENGAGE/ENSURE investigators. Two doses of corifollitropin alfa allow for similar exposure and ovarian response in patients weighing ≤60 kg and >60 kg Hum Reprod 24 Suppl 1 2009 i114
9. B.C. Tarlatzis, B.C. Fauser, E.M. Kolibianakis, K. Diedrich, and P. Devroey GnRH antagonists in ovarian stimulation for IVF Hum Reprod Update 12 2006 333 340
10. E.M. Heijnen, M.J. Eijkemans, C. De Klerk, S. Polinder, N.G. Beckers, and E.R. Klinkert A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial Lancet 369 2007 743 799
11. M.F. Verberg, M.J. Eijkemans, E.M. Heijnen, F.J. Broekmans, C. de Klerk, and B.C.J.M. Fauser Why do couples drop out from IVF treatment? A prospective cohort study Hum Reprod 23 2008 2050 2055
12. P. Devroey, M. Aboulghar, J. Garcia-Velasco, G. Griesinger, P. Humaidan, and E. Kolibianakis Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment Hum Reprod 24 2009 764 774
13. E.M. Kolibianakis, J. Collins, B.C. Tarlatzis, P. Devroey, K. Diedrich, and G. Griesinger Among subjects treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis Hum Rep Update 12 2006 651 671
14. E.G. Papanikolaou, M. Camus, E.M. Kolibianakis, L. van Landuyt, A. van Steirteghem, and P. Devroey In vitro fertilization with single blastocyst-stage versus single cleavage stage embryos N Engl J Med 354 2006 1139 1146
15. North American Ganirelix Study Group Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation Fertil Steril 75 2001 38 45
16. A.N. Andersen, P. Devroey, and J.C. Arce Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial Hum Reprod 21 2006 3217 3227
17. A.H. Balen, A.G. Mulders, B.C. Fauser, B.C. Schoot, M.A. Renier, and P. Devroey Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility J Clin Endocrinol Metab 89 2004 6297 6304
18. E.G. Papanikolaou, C. Pozzobon, E.M. Kolibianakis, M. Camus, H. Tournaye, and H.M. Fatemi Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles Fertil Steril 85 2006 112 120
19. R.S. Mathur, V.A. Akande, S.D. Keay, L.P. Hunt, and J.M. Jenkins Distinction between early and late ovarian hyperstimulation syndrome Fertil Steril 73 2000 901 907
20. G.R. Verwoerd, T. Mathews, and P.R. Brinsden Optimal follicle and oocyte numbers for cryopreservation of all embryos in IVF cycles at risk of OHSS Reprod Biomed Online 17 2008 312 317
21. E.G. Papanikolaou, E.M. Kolibianakis, H. Tournaye, C.A. Venetis, H.M. Fatemi, and B. Tarlatzis Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis Hum Reprod 23 2008 91 99